Your browser doesn't support javascript.
loading
Indoleamine 2,3-dioxygenase provides adaptive resistance to immune checkpoint inhibitors in hepatocellular carcinoma.
Brown, Zachary J; Yu, Su Jong; Heinrich, Bernd; Ma, Chi; Fu, Qiong; Sandhu, Milan; Agdashian, David; Zhang, Qianfei; Korangy, Firouzeh; Greten, Tim F.
Afiliação
  • Brown ZJ; Thoracic and GI Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Building 10, Room 3B43, Bethesda, MD, 20892, USA.
  • Yu SJ; Thoracic and GI Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Building 10, Room 3B43, Bethesda, MD, 20892, USA.
  • Heinrich B; Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, South Korea.
  • Ma C; Thoracic and GI Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Building 10, Room 3B43, Bethesda, MD, 20892, USA.
  • Fu Q; Thoracic and GI Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Building 10, Room 3B43, Bethesda, MD, 20892, USA.
  • Sandhu M; Thoracic and GI Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Building 10, Room 3B43, Bethesda, MD, 20892, USA.
  • Agdashian D; Thoracic and GI Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Building 10, Room 3B43, Bethesda, MD, 20892, USA.
  • Zhang Q; Thoracic and GI Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Building 10, Room 3B43, Bethesda, MD, 20892, USA.
  • Korangy F; Thoracic and GI Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Building 10, Room 3B43, Bethesda, MD, 20892, USA.
  • Greten TF; Thoracic and GI Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Building 10, Room 3B43, Bethesda, MD, 20892, USA.
Cancer Immunol Immunother ; 67(8): 1305-1315, 2018 08.
Article em En | MEDLINE | ID: mdl-29959458

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Indolamina-Pirrol 2,3,-Dioxigenase / Neoplasias Hepáticas Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Indolamina-Pirrol 2,3,-Dioxigenase / Neoplasias Hepáticas Idioma: En Ano de publicação: 2018 Tipo de documento: Article